Skip to content
drillr.ai
Sign up

RAPP

Rapport Therapeutics, Inc. Common Stock

NASDAQ · Healthcare · Biotechnology · US

$45.77
−3.95%
Ask drillr
0
Insider buys (3m)
20
Insider sells (3m)
-$7.1M
Net value (3m)
+29.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale16,201$51
Aug 26, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale18,921$50
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale13,160$50
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale20,799$50
Aug 20, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale404$50
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale14,171$46
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale8,370$47
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale3,664$47
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale19,500$48
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale5,794$49
Jul 29, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale2,203$42
Jul 29, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale7$43
Jul 15, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale2,729$41
Jul 15, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale5,481$40
Jul 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale1,000$43
Jul 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale1,900$40
Jul 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale3,792$41
Jul 1, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale876$40
Jul 1, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale7,344$40
Jul 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale3,308$42
Jun 10, 2026HEALY JAMES · directorA-Award15,200$35
Jun 10, 2026Silva Paul M · directorA-Award15,200$35
Jun 10, 2026PAUL STEVEN M · directorA-Award15,200$35
Jun 10, 2026PEREZ ROBERT J · directorA-Award15,200$35
Jun 10, 2026MARAGANORE JOHN · directorA-Award15,200$35
Jun 10, 2026Sanchez Ramiro · directorA-Award15,200$35
Jun 10, 2026Young Wendy B. · directorA-Award15,200$35
Jun 10, 2026Huber Reid M · directorA-Award15,200$35
May 28, 2026Third Rock Ventures V, L.P. · 10 percent ownerSale18,572$40
May 13, 2026Third Rock Ventures V, L.P. · 10 percent ownerSale133,618$40
Institutional positioning

13F filings over the trailing two quarters

New 60Increased 110Reduced 84Sold out 13
FilerActionSharesFiled
FMR LLCIncreased7,172,894Aug 13, 2026
FMR LLCIncreased7,168,939May 15, 2026
TRV GP V, LLCUnchanged7,135,233May 7, 2026
TRV GP V, LLCReduced6,280,525Aug 10, 2026
ARCH Venture Management, LLCUnchanged3,728,738Aug 14, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged3,728,738May 15, 2026
CAPITAL INTERNATIONAL INVESTORSReduced3,097,973May 13, 2026
GOLDMAN SACHS GROUP INCIncreased3,001,879Mar 25, 2026
CORMORANT ASSET MANAGEMENT, LPReduced2,957,521May 15, 2026
GOLDMAN SACHS GROUP INCReduced2,942,251May 15, 2026
Capital International InvestorsReduced2,921,958Aug 12, 2026
GOLDMAN SACHS GROUP INCReduced2,910,449Aug 14, 2026
BlackRock, Inc.Increased2,699,786Aug 7, 2026
Cormorant Asset Management, LPReduced2,657,521Aug 14, 2026
BLACKROCK, INC.Increased2,505,955May 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026